GILEAD SCIENCES, INC. Underwriting AgreementUnderwriting Agreement • September 29th, 2020 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • New York
The Securities will be issued pursuant to an Indenture dated as of March 30, 2011 (the “Base Indenture”) between the Company and Wells Fargo Bank, National Association, as trustee (the “Trustee”), as supplemented by a supplemental indenture to be dated as of September 30, 2020 (together with the Base Indenture, the “Indenture”).
